UBS Group’s Global Cord Blood Corporation CO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,238
| Closed | -$3.7K | – | 10426 |
|
|
2023
Q1 | $3.7K | Hold |
1,238
| – | – | ﹤0.01% | 8289 |
|
|
2022
Q4 | $3.7K | Hold |
1,238
| – | – | ﹤0.01% | 9465 |
|
|
2022
Q3 | $4K | Buy |
1,238
+661
| +115% | +$1.62K | ﹤0.01% | 9497 |
|
|
2022
Q2 | $2K | Buy |
+577
| New | +$1.79K | ﹤0.01% | 9770 |
|
|
2021
Q4 | – | Sell |
-413
| Closed | -$2K | – | 11435 |
|
|
2021
Q3 | $2K | Buy |
+413
| New | +$2.03K | ﹤0.01% | 9118 |
|
|
2021
Q2 | – | Sell |
-419
| Closed | -$2K | – | 10411 |
|
|
2021
Q1 | $2K | Sell |
419
-443
| -51% | -$1.92K | ﹤0.01% | 8731 |
|
|
2020
Q4 | $3K | Buy |
862
+127
| +17% | +$487 | ﹤0.01% | 8067 |
|
|
2020
Q3 | $3K | Hold |
735
| – | – | ﹤0.01% | 7614 |
|
|
2020
Q2 | $2K | Sell |
735
-1,365
| -65% | -$3.96K | ﹤0.01% | 7716 |
|
|
2020
Q1 | $7K | Sell |
2,100
-56
| -3% | -$245 | ﹤0.01% | 7197 |
|
|
2019
Q4 | $11K | Sell |
2,156
-1,182
| -35% | -$5.64K | ﹤0.01% | 7265 |
|
|
2019
Q3 | $16K | Sell |
3,338
-3,228
| -49% | -$16.9K | ﹤0.01% | 6901 |
|
|
2019
Q2 | $38K | Sell |
6,566
-356,177
| -98% | -$2.35M | ﹤0.01% | 6158 |
|
|
2019
Q1 | $2.55M | Buy |
362,743
+16,587
| +5% | +$110K | ﹤0.01% | 2787 |
|
|
2018
Q4 | $2.23M | Buy |
+346,156
| New | +$2.21M | ﹤0.01% | 2927 |
|
|
2017
Q3 | – | Sell |
-5,739
| Closed | -$55K | – | 8247 |
|
|
2017
Q2 | $55K | Sell |
5,739
-828
| -13% | -$6.61K | ﹤0.01% | 5587 |
|
|
2017
Q1 | $44K | Buy |
6,567
+770
| +13% | +$4.56K | ﹤0.01% | 5617 |
|
|
2016
Q4 | $35K | Buy |
5,797
+2,653
| +84% | +$13.2K | ﹤0.01% | 6125 |
|
|
2016
Q3 | $16K | Hold |
3,144
| – | – | ﹤0.01% | 6497 |
|
|
2016
Q2 | $18K | Sell |
3,144
-2,090
| -40% | -$12.7K | ﹤0.01% | 6400 |
|
|
2016
Q1 | $32K | Buy |
5,234
+2,090
| +66% | +$12.5K | ﹤0.01% | 5849 |
|
|
2015
Q4 | $20K | Hold |
3,144
| – | – | ﹤0.01% | 6779 |
|
|
2015
Q3 | $19K | Hold |
3,144
| – | – | ﹤0.01% | 6770 |
|
|
2015
Q2 | $19K | Sell |
3,144
-302
| -9% | -$1.85K | ﹤0.01% | 6937 |
|
|
2015
Q1 | $18K | Buy |
+3,446
| New | +$17K | ﹤0.01% | 7109 |
|
Other funds holding CO
UB
OA
SPIA
UBS Group's CO Position: Q2 2023 in Review
UBS Group sold out of Global Cord Blood Corporation (CO) in Q2 2023, closing a stake of 1,238 shares — an estimated $3.7K sold.
UBS Group first reported a position in CO in Q1 2015 and held it in 25 quarters. The position peaked at $2.55M in Q1 2019. 6 funds tracked by Wall St. Rank hold CO as of Q2 2023.
- UBS Group reported no remaining Global Cord Blood Corporation position as of Q2 2023 after selling out during the quarter.
- UBS Group sold 1,238 Global Cord Blood Corporation shares in Q2 2023, an estimated $3.7K.
- UBS Group first reported a position in Global Cord Blood Corporation in Q1 2015 and held it in 25 quarters.
- UBS Group's Global Cord Blood Corporation position peaked at $2.55M in Q1 2019.
- 6 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2023.
Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.